Skip to main content

Mason Carrico

Analyst

Stevens

Equibles does not estimate personal net worth.

About Mason Carrico

Mason Carrico is recorded as Analyst at Stevens. Mason Carrico has spoken on 9 earnings calls across 7 companies, most recently for Alphatec Holdings, Inc. on August 4, 2026. Those appearances were for Establishment Labs Holdings Inc. (ESTA), Insight Molecular Diagnostics Inc. (IMDX), Alphatec Holdings, Inc. (ATEC), 10x Genomics, Inc. (TXG), Castle Biosciences Inc (CSTL) and 2 other companies. The companies whose calls Mason Carrico spoke on are classified in the Healthcare sector.

Mason Carrico on recent calls

“On new surgeon users, have you seen any change in the composition of what new surgeons buy first historically? I know that lateral was the entry point, but is the larger share coming from, or I guess recent new ads at least, coming from surgeons starting in cervical or some other category?”
Analyst — Stevens, Alphatec Holdings, Inc. Q2 FY2026 Earnings Call ·
“I was just wondering if you could provide, I guess, a bit more detail on spatial instrument revenue this year. I mean, how material is, you know, the Q1 to Q2 sequential decline?”
Analyst — Stevens, 10x Genomics, Inc. Q1 FY2026 Earnings Call ·
“I assume that most, if not all, Preserve users were already Motiva users, but I was curious to hear if that launch had actually led to increased conversation or maybe even conversion of accounts that previously hadn't adopted Motiva.”
Analyst — Stevens, Establishment Labs Holdings Inc. Q1 FY2026 Earnings Call ·
“I wanted to start out with Pissue Cypher volume, 58% growth year over year, obviously. That's great growth, but volumes did decline very modestly quarter over quarter.”
Analyst — Stevens, Castle Biosciences Inc Q1 FY2026 Earnings Call ·
“Could you characterize, I guess, what percentage of the sales funnel today is being driven more by, you know, bottoms-up, surgeon champion versus top-down admin of these larger systems? um are you seeing you know the new launch team attract more surgeon champions to deals um that are sourced you know top down today…”
Analyst — Stevens, PROCEPT BioRobotics Corp Q1 FY2026 Earnings Call ·

Affiliation history

  • Stevens

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity